Substantia nigra Smad3 signaling deficiency: relevance to aging and Parkinson’s disease and roles of microglia, proinflammatory factors, and MAPK

Abstract

Background Smad3 signaling is indicated to regulate microglia activity. Parkinson’s disease (PD) neurodegeneration is shown to be associated with aging and neuroinflammation. However, it remains unclear about the relationship among Smad3 signaling, aging, neuroinflammation, and PD. Methods Rats were treated with SIS3 (a specific inhibitor of Smad3, intranigal injection) and/or lipopolysaccharide (intraperitoneal injection). We investigated the effect of SIS3 and lipopolysaccharide and their mechanism of action on motor behavior and nigrostriatal dopaminergic system in the rats. Furthermore, we explored the effect of SIS3 and LPS and their potential signaling mechanism of action on inflammatory response by using primary microglial cultures. Finally, we investigated the relationship among aging, Smad3 signaling, and neuroinflammation using animals of different ages. Results Both SIS3 and lipopolysaccharide induced significant behavior deficits and nigrostriatal dopaminergic neurodegeneration in the rats compared with the vehicle-treated (control) rats. Significantly increased behavior deficits and nigrostriatal dopaminergic neurodegeneration were observed in the rats co-treated with SIS3 and lipopolysaccharide compared with the rats treated with vehicle, SIS3, or lipopolysaccharide. Furthermore, both SIS3 and lipopolysaccharide induced significant microglia activation and proinflammatory factor (IL-1β, IL-6, iNOS, and ROS) level increase in the SN of rats compared with the control rats. Significantly enhanced microglial inflammatory response was observed in the rats co-treated with SIS3 and lipopolysaccharide compared with the other three groups. For our in vitro study, both SIS3 and lipopolysaccharide induced significant proinflammatory factor level increase in primary microglia cultures compared with the control cultures. Significantly increased inflammatory response was observed in the cultures co-treated with SIS3 and lipopolysaccharide compared with the other three groups. MAPK (ERK/p38) contributed to microglial inflammatory response induced by co-treatment with SIS3 and lipopolysaccharide. Interestingly, there was decrease in Smad3 and pSmad3 expression (protein) and enhancement of neuroinflammation in the mouse SN with aging. Proinflammatory factor levels were significantly inversely correlated with Smad3 and pSmad3 expression. Conclusion Our study strongly indicates the involvement of SN Smad3 signaling deficiency in aging and PD neurodegeneration and provides a novel molecular mechanism underlying the participation of aging in PD and helps to elucidate the mechanisms for the combined effect of multiple factors in PD.

Neurodegenerative Disorder Risk in Krabbe Disease Carriers

“…RACK1 is actually suggested modulating VIME by controlling STAT1, STAT3, AP-1, HIF1A, and SMAD3 transcription factors, PKC and AKT kinases as well as the protein phosphatase 2A (PP2A catalytic), and the actin-network component filamin-A. Notably, all these interactors are known to play key roles in NS physiology and their dysfunctions have been associated with several neuropathies, including tauopathies [ 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 ].…”

Integrative analysis of GWAS and co-localisation data suggests novel genes associated with age-related multimorbidity

“…A further four genes have links to the Hallmarks of Ageing, including TBX3 (T-box transcription factor 3) a regulator of cellular senescence (Kumar P et al 2014). SMAD3 (SMAD family member 3) is a regulator of inflammation and an inhibitor of PPARG expression (Tan et al 2004); decreased expression of the orthologue Smad3 has been linked to ageing, neuroinflammation, and neurodegeneration in mouse models (Liu et al 2020). LDLR (low density lipoprotein receptor) and APOB (apolipoprotein B) are involved in proteostasis and nutrient signalling.…”

Botulinum neurotoxin A ameliorates depressive-like behavior in a reserpine-induced Parkinson’s disease mouse model via suppressing hippocampal microglial engulfment and neuroinflammation

“…Specifically, complement C3-C3aR, CX3CL1-CX3CR1, CSF1-CSF1R, and purinergic signaling via P2RX7 and P2RY12 are implicated in microglia-mediated neuronal remodeling [74]. In several rodent model studies, microglial cells in the substantia nigra and hypothalamus were found to be reactive following chronic and sub-chronic stress [75,76]. However, the critical role of microglia in Parkinson's disease with depression is obscure.…”